Selective phosphorylation of adult tau isoforms in mature hippocampal neurons exposed to fibrillar aβ

Molecular and Cellular Neurosciences

Volumn 9, Issue 3, 1997, Pages 220-234

  Ferreira, Adriana ^a   Lu, Qun ^a   Orecchio, Lisa ^a   Kosik, Kenneth S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAU PROTEIN;

ANIMAL TISSUE; ARTICLE; EMBRYO; HIPPOCAMPUS; NERVE CELL DEGENERATION; NEUROFIBRILLARY TANGLE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; RNA SPLICING; SENILITY;

ANIMALIA;

EID: 0030879686     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcne.1997.0615     Document Type: Article

References (54)

1. Arioki M., Tsukamoto M., Ishiguro K., Kato R., Sato, Imahori K., Uchita T. Tau protein kinase II is involved in the regulation of the normal phosphorylation state of tau protein. J. Neurochem. 60:1993;461-468.
2. Bauman K., Mandelkow E-M., Biernat J., Piwnica-Worms H., Mandelkow E. Abnormal Alzheimer's like phosphorylation of tau protein by cyclin-dependent cdk2 and cdk5. FEBS Lett. 36:1993;417-424.
3. Bensadaun A., Weinstein R. Assay of protein in the presence of interfering material. Anal. Biochem. 70:1976;241-250.
4. Bottenstein J. E., Sato G. H. Growth of a rat neuroblastoma cell line in serum-free supplemented media. Proc. Natl. Acad. Sci. USA. 76:1979;514-517.
5. Bramblett G. T., Goedert M., Jakes R., Merrick S. E., Trojanowski J. Q., Lee V. M.-Y. Abnormal tau phosphorylation at Ser 396 in Alzheimer's disease recapitulates development and contributes to reduce microtubule binding. Neuron. 10:1993;1089-1099.
6. Brion J. P., Smith C., Couck A. M., Gallo J. M., Anderton B. H. Developmental changes in τ phosphorylation: Foetal τ is transiently phosphorylated in a manner similar to paired helical filament τ characteristic of Alzheimer's disease. J. Neurochem. 61:1993;2071-2080.
7. Busciglio J., Lorenzo A., Yeh J., Yankner B. A. β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron. 14:1995;879-888.
8. Caceres A., Kosik K. S. Inhibition of neuronal polarity by tau antisense oligonucleotides in primary cerebellar neurones. Nature. 343:1990;461-463.
9. Chin L., Li L., Ferreira A., Kosik K. S., Greengard P. Impairment of axonal development and of synaptogenesis in hippocampal neurons of synapsin I-deficient mice. Proc. Natl. Acad. Sci. USA. 92:1995;9230-9234.
10. Craig A. M., Banker G. A. Neuronal polarity. Annu. Rev. Neurosci. 17:1994;267-310.
11. mpkrsk. Proc. Natl. Aca. Sci. USA. 88:1991;4981-4985.
12. Dotti C. G., Sullivan C. A., Banker G. A. The establishment of polarity by hippocampal neurons in culture. J. Neurosci. 8:1988;1454-1468.
13. Drechsel D. N., Hyman A. A., Cobb M. H., Kirschner M. Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau. Mol. Biol. Cell. 3:1992;1141-1154.
14. Drewes G., Lichtenberg-Kragg B., Doring F., Mandelkow E-M., Biernat J., Doree M., Mandelkow E. Mitogen activated protein (MAP) kinase transform tau protein into an Alzheimer-like state. EMBO J. 11:1992;2131-2138.
15. Eldar-Finkelman H., Seger R., Vandenheede J. R., Krebs E. G. Inactivation of glycogen synthase kinase-3 by epidermal growth factor is mediated by mitogen-activated protein kinase/p90 ribosomal protein S6 kinase signaling pathway in NIH/3T3 cells. J. Biol. Chem. 270:1995;987-990.
16. Ferreira A., Busciglio J., Caceres A. Microtubule formation and neurite growth in cerebellar macroneurons which develop in vitro: evidence for the involvement of the microtubule-associated proteins, MAP-1a, HMW-MAP-2 and tau. Dev. Brain Res. 49:1989;215-228.
17. Ferreira A., Han H.-Q., Greengard P., Kosik K. S. Suppression of synapsin II inhibits the formation and maintenance of synapses in hippocampal culture. Proc. Natl. Acad. Sci. USA. 92:1995;9225-9229.
18. Fletcher T. L., Cameron P., DeCamilli P., Banker G. The distribution of synapsin I and synaptophysin in hippocampal neurons in culture. J. Neurosci. 11:1991;1617-1626.
19. Giovanelli L., Casamenti F., Scali C., Bartolini L., Pepeu G. Differential effects of amyloid peptides β-(1-40) and β-(25-35) injections into the rat nucleus basalis. Neuroscience. 66:1995;781-792.
20. Goedert M., Spillatine M. G., Jakes R., Rutherford D., Crowther R. A. Multiple isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron. 3:1989;519-526.
21. Goedert M., Cohen E. S., Jakes R., Cohen P. p42 MAP kinase phosphorylation sites in microtubule-associated protein tau are dephosphorylated by protein phosphatase 2A. FEBS Lett. 312:1992;95-99.
22. Goedert M., Jakes R., Crowther R. A., Six J., Lubke U., Vandermeeren M., Cras P., Trojanowski J. Q., Lee V. M.-Y. The abnormal phosphorylation of tau proteins at Ser-202 in Alzheimer's disease recapitulates phosphorylation during development. Proc. Natl. Acad. Sci. USA. 90:1993;5066-5070.
23. Goedert M., Jakes R. Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. EMBO J. 9:1990;4225-4230.
24. Goslin K., Banker G. A. Culturing Nerve Cells. 1991;MIT Press, Cambridge. p. 251-283.
25. Greenberg S. M., Koo E. H., Selkoe D. J., Qui W. Q., Kosik K. S. Secreted beta-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances tau phosphorylation. Proc. Natl. Acad. Sci. USA. 91:1994;7104-7108.
26. Hanger D. P., Hughes K., Woodgett J. R., Brion J. P., Anderton B. H. Glycogen synthase kinase 3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal colocalization of the kinase. Neurosci. Lett. 147:1992;58-62.
27. Harris K. A., Oyler G. A., Doolittle G. M., Vincent I., Lehman R. A. W., Kincaid R. L., Billingsley M. L. Okadaic acid induces hyperphosphorylated forms of tau protein in human brain slices. Ann. Neurol. 33:1993;77-87.
28. Jan R., Schiebler W., Greengard P. A quantitative dot immunobinding assay for proteins using nitrocellulose membrane filters. Proc. Natl. Acad. Sci. USA. 81:1984;1684-1687.
29. Knops J., Kosik K. S., Lee G., Pardee J., Cohen-Gould L., McConlogue L. Overexpression of tau in a nonneuronal cell induces long cellular processes. J. Cell Biol. 114:1991;725-733.
30. Kobayashi S., Ishiguro K., Omori A., Takamatsu M., Arioka M., Imahori K., Uchita T. A cdc-related kinase PSSALRE/cdk5 is homologous with the 30 kDa subunit of tau protein kinase II, a proline-directed protein kinase associated with microtubules. FEBS Lett. 335:1993;171-175.
31. Kosik K. S., Selkoe D. J. Experimental models of neurofibrillary disease. Marotta C. Neurofilaments. 1983;Minnesota Press, Minneapolis.
32. Kosik K. S., Orecchio L., Binder L. I., Trojanowski J., Lee V., Lee G. Epitopes that span the tau molecule are shared with paired helical filaments. Neuron. 1:1988;817-825.
33. Kosik K. S., Orecchio L., Bakalis S., Neve R. Developmentally regulated expression of specific tau sequences. Neuron. 2:1989;1389-1397.
34. Laemmli U. K. Cleavage of structural protein during the assembly of the head of the bacteriophage T4. Nature. 227:1970;680-685.
35. Ledesma M. D., Correas L., Avila J., Diaz-Nido J. Implication of brain cdc2 and MAP kinases in the phosphorylation of tau proteins in Alzheimer's disease. FEBS Lett. 308:1992;218-224.
36. Lee G., Cowan N., Kirschner M. The primary structure and heterogeneity of tau protein from mouse brain. Science. 239:1988;285-288.
37. Lorenzo A., Yankner B. A. β-Amyloid neurotoxicity requires fibril formation and it is inhibited by Congo red. Proc. Natl. Acad. Sci. USA. 91:1994;12243-12247.
38. Lowry O. H., Resebrough N. J., Farr A. L., Randall R. J. Protein measurements with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
39. Mandelkow E.-M., Drewes G., Biernat J., Gustke N., Van Lint J., Vandenheede J. R., Mandelkow E. Glycogen synthase kinase 3 and the Alzheimer's disease-like state of microtubule-associated protein tau. FEBS Lett. 314:1992;315-321.
40. Matsuo E. S., Shin R.-W., Billingsley M. L., Van deVoorde A., O'Connor M., Trojanowski J. Q., Lee V. M. Y. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron. 13:1994;989-1002.
41. Medina M., Garcia-Rocha M., Padilla R., Perez M., Montejo de Garcini E., Avila J. Protein kinases involved in the phosphorylation of human tau protein in transfected COS-1 cells. FEBS Lett. 19:1996;20-30.
42. Neve R. L., Haris P., Kosik K. S., Kurnit D. M., Donlon T. A. Identification of cDNA clones for the human microtubule-associated protein tau, and chromosomal localization of the genes for tau and microtubule associated protein 2. Mol. Brain Res. 1:1986;271-280.
43. Paudel H. K., Lew J., Zenobia A., Wang J. H. Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments. J. Biol. Chem. 268:1993;23512-23518.
44. Pike C. J., Walencewicz-Wasserman A. J., Kosmoski, Cribbs D. H., Glabe C. G., Cotman C. W. Structure-activity analyses of β-amyloid peptides: Contributions of the β25-35 region to aggregation and neurotoxicity. J. Neurochem. 64:1995;253-265.
45. Smith C. J., Anderton B. H., Davies D., Gallo J. M. Tau isoform expression and phosphorylation state during differentiation of cultured neuronal cells. FEBS Lett. 375:1995;243-248.
46. Sturgill T. W., Ray L. B., Erikson E., Maller J. L. Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature. 334:1988;715-719.
47. Sutherland C., Cohen P. The α-isoform of glycogen synthase kinase-3 from rabbit skeletal muscle is inactivated by p70 S6 kinase or MAP kinase-activated protein kinase-1 in vitro. FEBS Lett. 338:1994;37-42.
48. Sutherland C., Leighton I. A., Cohen P. Inactivation of glycogen synthase kinase-3β by phosphorylation: New kinase connections in insulin and growth factor signalling. Biochem. J. 296:1993;15-19.
49. Takashima A., Noguchi K., Sato K., Hoshimo T., Imahori K. Tau protein kinase I is essential for β-protein induced neurotoxicity. Proc. Natl. Acad. Sci. USA. 90:1993;7789-7793.
50. Temple S., Raff M. C. Clonal analysis of oligodendrocyte development in culture: Evidence for a developmental clock that counts cell divisions. Cell. 44:1986;773-779.
51. Towbin H., Staehelein T., Gordon J. Electrophoretic transfer of protein from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4354-4356.
52. Vulliet R., Halloran S. M., Braun R. K., Smith A. J., Lee G. Proline-directed phosphorylation of human tau protein. J. Biol. Chem. 267:1992;22570-22574.
53. Yanker B. A., Duffy L. K., Kirschner D. A. Nerotrophic and neurotoxic effects of amyloid β-protein: Reversal by tachykinin neuropeptides. Science. 250:1990;279-282.
54. Wang Q. M., Roach P., Fiol C. J. Use of a synthetic peptide as a selective substrate for glycogen synthase kinase 3. Anal. Biochem. 220:1994;397-402.